SARS-CoV-2 antibody progression and neutralizing potential in mild symptomatic COVID-19 patients – a comparative long term post-infection study

BACKGROUND: Since December 2019, SARS-CoV-2 has been keeping the world in suspense. Rapid tests, molecular diagnosis of acute infections, and vaccination campaigns with vaccines are building blocks of strategic pandemic control worldwide. For laboratory diagnostics, the quantification of the antibod...

Descripción completa

Detalles Bibliográficos
Autores principales: Brehm, Jessica, Spaeth, Alexander, Dreßler, Lars, Masetto, Thomas, Dannenberg, Rainer, Peter, Christoph, Grimmler, Matthias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428854/
https://www.ncbi.nlm.nih.gov/pubmed/36059441
http://dx.doi.org/10.3389/fimmu.2022.915338

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428854/
https://www.ncbi.nlm.nih.gov/pubmed/36059441
http://dx.doi.org/10.3389/fimmu.2022.915338

Ejemplares similares